GENERAL10 Sept 2026
Molbio Diagnostics hits 20% upper circuit on heavy volume; up 35% in 2 days
Molbio Diagnostics shares jumped 35% in just two days. On September 10, 2026, the stock was locked at the 20% upper circuit at ₹1,509.70 on the BSE (Bombay Stock Exchange). That is 87% above its initial public offer (IPO) price of ₹807. If you hold or track this stock, treat the sharp rally calmly and check the basics before acting.
Key Statutory Highlights
- Molbio Diagnostics share price rose 35% over the last two days.
- The stock was locked at the 20% upper circuit at ₹1,509.70 on the BSE.
- This price is 87% higher than its IPO price of ₹807 per share.
Actionable Advice for Taxpayers / Founders:If you hold or are watching this stock, review your own holding period and risk comfort before taking any buy or sell call, since a circuit-locked price can limit your ability to trade at will.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: